WingerchukDMLennonVALucchinettiCF. The spectrum of neuromyelitis optica. Lancet Neurol2007; 6: 805–815.
2.
SellnerJBoggildMClanetM. EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol2010; 17: 1019–1032.
3.
JariusSWildemannB.The history of neuromyelitis optica. J Neuroinflamm2013; 10: 8.
4.
TrebstCJariusSBertheleA. Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS). J Neurol2014; 261: 1–16.
5.
EichelRMeinerZAbramskyO. Acute disseminating encephalomyelitis in neuromyelitis optica: Closing the floodgates. Arch Neurol2008; 65: 267–271.
6.
SaikiSUenoYMoritaniT. Extensive hemispheric lesions with radiological evidence of blood-brain barrier integrity in a patient with neuromyelitis optica. J Neurol Sci2009; 284: 217–219.
7.
TasakiAShimizuFSanoY. Autocrine MMP-2/9 secretion increases the BBB permeability in neuromyelitis optica. J Neurol Neurosurg Psychiatry2014; 85: 419–430.
8.
LiYXiePLvF. Brain magnetic resonance imaging abnormalities in neuromyelitis optica. Acta Neurol Scand2008; 118: 218–225.
9.
PittockSJLennonVAKreckeK. Brain abnormalities in neuromyelitis optica. Arch Neurol2006; 63: 390–396.
10.
NakajimaHFujikiYItoT. Anti-aquaporin-4 antibody-positive neuromyelitis optica presenting with syndrome of inappropriate antidiuretic hormone secretion as an initial manifestation. Case Report Neurol2011; 3: 263–267.
11.
NakanoTFujimotoTFukudaY. Neuromyelitis optica with syndrome of inappropriate secretion of antidiuretic hormone and hypersomnia associated with bilateral hypothalamic lesions: A case report. Rinsho Shinkeigaku2011; 51: 599–602.
12.
YouXFQinWHuWL.Aquaporin-4 antibody positive neuromyelitis optica with syndrome of inappropriate antidiuretic hormone secretion. Neurosciences (Riyadh)2011; 16: 68–71.
13.
BreningstallGN.An 11-year-old girl with syndrome of inappropriate antidiuretic hormone secretion. Semin Pediatr Neurol1999; 6: 202–208.
14.
IorioRLucchinettiCFLennonVA. Syndrome of inappropriate antidiuresis may herald or accompany neuromyelitis optica. Neurology2011; 77: 1644–1646.
15.
PittockSJWeinshenkerBGLucchinettiCF. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4expression. Arch Neurol2006; 63: 964–968.
16.
SuzukiKNakamuraTHashimotoK. Hypothermia, hypotension, hypersomnia, and obesity associated with hypothalamic lesions in a patient positive for the anti-aquaporin 4 antibody: A case report and literature review. Arch Neurol2012; 69: 1355–1359.
17.
NishinoSOkuroMKotoriiN. Hypocretin/orexin and narcolepsy: New basic and clinical insights. Acta Physiol (Oxf)2010; 198: 209–222.
18.
Roper-HallGChungSMCruzOA.Ocular neuromyotonia: Differential diagnosis and treatment. Strabismus2013; 21: 131–136.
19.
ParkHYHwangJMKimJS.Abducens neuromyotonia due to internal carotid artery aneurysm. J Neurol Sci2008; 270: 205–208.
20.
OohiraASonobeA.A case of Tolosa-Hunt syndrome presenting ocular neuromyotonia. Rinsho Shinkeigaku2013; 53: 376–379.
21.
WatersPJMcKeonALeiteMI. Serologic diagnosis of NMO: A multicenter comparison of aquaporin-4-IgG assays. Neurology2012; 78: 665–671.
22.
JariusSWildemannB.Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: A critical review of the literature. Brain Pathol2013; 23: 661–683.
23.
BertsiasGKIoannidisJPAringerM. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: Report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis2010; 69: 2074–2082.
24.
JariusSJacobiCde SezeJ. Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders. Mult Scler2011; 17: 1067–1073.
25.
EstiasariRMatsushitaTMasakiK. Comparison of clinical, immunological and neuroimaging features between anti-aquaporin-4 antibody-positive and antibody-negative Sjogren’s syndrome patients with central nervous system manifestations. Mult Scler2012; 18: 807–816.
26.
WingerchukDMWeinshenkerBG.The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease. Mult Scler2012; 18: 5–10.
27.
ZávadaJNytrováPWandingerKP. Seroprevalence and specificity of NMO-IgG (anti-aquaporin 4 antibodies) in patients with neuropsychiatric systemic lupus erythematosus. Rheumatol Int2013; 33: 259–263.
28.
MinJHKimHJKimBJ. Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: Association with neuromyelitis optica. Mult Scler2009; 15: 1069–1076.
29.
LucchinettiCFGuoYPopescuBF. The pathology of an autoimmune astrocytopathy: Lessons learned from neuromyelitis optica. Brain Pathol2014; 24: 83–97.
30.
MisuTHöftbergerRFujiharaK. Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica. Acta Neuropathol2013; 125: 815–827.
